APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioid Narcotics

Compare research editions
View pricing & licenses

Selected research

Industry Research

Opioid Narcotics Industry Research Report 2026

27 December 2025129 pages

Choose your research edition.

Industry ResearchOpioid Narcotics Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Narcotics Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Opioid Narcotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Narcotics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Narcotics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Opioid Narcotics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Opioid Narcotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Opioid Narcotics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Opioid Narcotics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Opioid Narcotics include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Reig Jofre, Pfizer, GSK and Fresenius Kabi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Opioid Narcotics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Opioid Narcotics Market by Company

Yichang Renfu Pharmaceutical Co., Ltd.

Jiangsu Enhua Pharmaceutical Co., Ltd.

Henan Lingrui Pharmaceutical Co., Ltd.

Sinopharm Group Industrial Co., Ltd. Langfang Branch

Changzhou Siyao Pharmaceutical Co., Ltd.

Reig Jofre

Pfizer

GSK

Fresenius Kabi

Daiichi Sankyo

AcelRx Pharmaceuticals, Inc

Abbott

Opioid Narcotics Segment by Type

Fentanyl

Remifentanil

Sufentanil

Opioid Narcotics Segment by Application

Hospital

Clinic

Other

Opioid Narcotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Narcotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Narcotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Narcotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Opioid Narcotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Opioid Narcotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Opioid Narcotics Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Opioid Narcotics Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Opioid Narcotics Sales Market Share by Manufacturers (2021-2026) Table 8. Global Opioid Narcotics Revenue of Manufacturers (2021-2026) Table 9. Global Opioid Narcotics Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Opioid Narcotics Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Opioid Narcotics Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Opioid Narcotics, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Opioid Narcotics, Product Type & Application Table 14. Global Opioid Narcotics Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Opioid Narcotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Yichang Renfu Pharmaceutical Co., Ltd. Company Information Table 19. Yichang Renfu Pharmaceutical Co., Ltd. Business Overview Table 20. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 22. Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments Table 23. Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information Table 24. Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview Table 25. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 27. Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Developments Table 28. Henan Lingrui Pharmaceutical Co., Ltd. Company Information Table 29. Henan Lingrui Pharmaceutical Co., Ltd. Business Overview Table 30. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 32. Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments Table 33. Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information Table 34. Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview Table 35. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio Table 37. Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Developments Table 38. Changzhou Siyao Pharmaceutical Co., Ltd. Company Information Table 39. Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview Table 40. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 42. Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments Table 43. Reig Jofre Company Information Table 44. Reig Jofre Business Overview Table 45. Reig Jofre Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Reig Jofre Opioid Narcotics Product Portfolio Table 47. Reig Jofre Recent Developments Table 48. Pfizer Company Information Table 49. Pfizer Business Overview Table 50. Pfizer Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Pfizer Opioid Narcotics Product Portfolio Table 52. Pfizer Recent Developments Table 53. GSK Company Information Table 54. GSK Business Overview Table 55. GSK Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. GSK Opioid Narcotics Product Portfolio Table 57. GSK Recent Developments Table 58. Fresenius Kabi Company Information Table 59. Fresenius Kabi Business Overview Table 60. Fresenius Kabi Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Fresenius Kabi Opioid Narcotics Product Portfolio Table 62. Fresenius Kabi Recent Developments Table 63. Daiichi Sankyo Company Information Table 64. Daiichi Sankyo Business Overview Table 65. Daiichi Sankyo Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Daiichi Sankyo Opioid Narcotics Product Portfolio Table 67. Daiichi Sankyo Recent Developments Table 68. AcelRx Pharmaceuticals, Inc Company Information Table 69. AcelRx Pharmaceuticals, Inc Business Overview Table 70. AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio Table 72. AcelRx Pharmaceuticals, Inc Recent Developments Table 73. Abbott Company Information Table 74. Abbott Business Overview Table 75. Abbott Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Abbott Opioid Narcotics Product Portfolio Table 77. Abbott Recent Developments Table 78. Global Opioid Narcotics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Opioid Narcotics Sales by Region (2021-2026) & (K Units) Table 80. Global Opioid Narcotics Sales Market Share by Region (2021-2026) Table 81. Global Opioid Narcotics Sales by Region (2027-2032) & (K Units) Table 82. Global Opioid Narcotics Sales Market Share by Region (2027-2032) Table 83. Global Opioid Narcotics Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Opioid Narcotics Revenue Market Share by Region (2021-2026) Table 85. Global Opioid Narcotics Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Opioid Narcotics Revenue Market Share by Region (2027-2032) Table 87. North America Opioid Narcotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 89. North America Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 90. North America Opioid Narcotics Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Opioid Narcotics Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Opioid Narcotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 94. Europe Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 95. Europe Opioid Narcotics Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Opioid Narcotics Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Opioid Narcotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 99. Asia Pacific Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 100. Asia Pacific Opioid Narcotics Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Opioid Narcotics Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Opioid Narcotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 104. South America Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 105. South America Opioid Narcotics Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Opioid Narcotics Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Opioid Narcotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 109. Middle East and Africa Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 110. Middle East and Africa Opioid Narcotics Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Opioid Narcotics Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 113. Global Opioid Narcotics Sales by Type (2027-2032) & (K Units) Table 114. Global Opioid Narcotics Sales Market Share by Type (2021-2026) Table 115. Global Opioid Narcotics Sales Market Share by Type (2027-2032) Table 116. Global Opioid Narcotics Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Opioid Narcotics Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Opioid Narcotics Revenue Market Share by Type (2021-2026) Table 119. Global Opioid Narcotics Revenue Market Share by Type (2027-2032) Table 120. Global Opioid Narcotics Price by Type (2021-2026) & (US$/Unit) Table 121. Global Opioid Narcotics Price by Type (2027-2032) & (US$/Unit) Table 122. Global Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 123. Global Opioid Narcotics Sales by Application (2027-2032) & (K Units) Table 124. Global Opioid Narcotics Sales Market Share by Application (2021-2026) Table 125. Global Opioid Narcotics Sales Market Share by Application (2027-2032) Table 126. Global Opioid Narcotics Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Opioid Narcotics Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Opioid Narcotics Revenue Market Share by Application (2021-2026) Table 129. Global Opioid Narcotics Revenue Market Share by Application (2027-2032) Table 130. Global Opioid Narcotics Price by Application (2021-2026) & (US$/Unit) Table 131. Global Opioid Narcotics Price by Application (2027-2032) & (US$/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Opioid Narcotics Distributors List Table 135. Opioid Narcotics Customers List Table 136. Opioid Narcotics Industry Trends Table 137. Opioid Narcotics Industry Drivers Table 138. Opioid Narcotics Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Opioid Narcotics Product Image Figure 5. Global Opioid Narcotics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Opioid Narcotics Market Size (2021-2032) & (US$ Million) Figure 7. Global Opioid Narcotics Sales (2021-2032) & (K Units) Figure 8. Global Opioid Narcotics Average Price (US$/Unit) & (2021-2032) Figure 9. Fentanyl Product Image Figure 10. Remifentanil Product Image Figure 11. Sufentanil Product Image Figure 12. Hospital Product Image Figure 13. Clinic Product Image Figure 14. Other Product Image Figure 15. Global Opioid Narcotics Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Opioid Narcotics, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Opioid Narcotics Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Opioid Narcotics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Opioid Narcotics Sales by Region in 2025 Figure 21. Global Opioid Narcotics Revenue by Region in 2025 Figure 22. North America Opioid Narcotics Market Size by Country in 2025 Figure 23. North America Opioid Narcotics Sales Market Share by Country (2021-2032) Figure 24. North America Opioid Narcotics Revenue Market Share by Country (2021-2032) Figure 25. United States Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Opioid Narcotics Market Size by Country in 2025 Figure 29. Europe Opioid Narcotics Sales Market Share by Country (2021-2032) Figure 30. Europe Opioid Narcotics Revenue Market Share by Country (2021-2032) Figure 31. Germany Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Opioid Narcotics Market Size by Country in 2025 Figure 42. Asia Pacific Opioid Narcotics Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Opioid Narcotics Revenue Market Share by Country (2021-2032) Figure 44. China Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Opioid Narcotics Market Size by Country in 2025 Figure 53. South America Opioid Narcotics Sales Market Share by Country (2021-2032) Figure 54. South America Opioid Narcotics Revenue Market Share by Country (2021-2032) Figure 55. Brazil Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Colombia Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Opioid Narcotics Market Size by Country in 2025 Figure 60. Middle East and Africa Opioid Narcotics Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Opioid Narcotics Revenue Market Share by Country (2021-2032) Figure 62. Egypt Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Opioid Narcotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Opioid Narcotics Sales Market Share by Type (2021-2032) Figure 68. Global Opioid Narcotics Revenue Market Share by Type (2021-2032) Figure 69. Global Opioid Narcotics Price (US$/Unit) by Type (2021-2032) Figure 70. Global Opioid Narcotics Sales Market Share by Application (2021-2032) Figure 71. Global Opioid Narcotics Revenue Market Share by Application (2021-2032) Figure 72. Global Opioid Narcotics Price (US$/Unit) by Application (2021-2032) Figure 73. Opioid Narcotics Value Chain Figure 74. Opioid Narcotics Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Opioid Narcotics Industry Opportunities and Challenges

Scope & coverage.

Types
  • Fentanyl
  • Remifentanil
  • Sufentanil
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yichang Renfu Pharmaceutical Co., Ltd.
  • Jiangsu Enhua Pharmaceutical Co., Ltd.
  • Henan Lingrui Pharmaceutical Co., Ltd.
  • Sinopharm Group Industrial Co., Ltd. Langfang Branch
  • Changzhou Siyao Pharmaceutical Co., Ltd.
  • Reig Jofre
  • Pfizer
  • GSK
  • Fresenius Kabi
  • Daiichi Sankyo
  • AcelRx Pharmaceuticals, Inc
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Opioid Narcotics Market Size (2021-2032)
  4. 2.2.2 Global Opioid Narcotics Sales (2021-2032)
  5. 2.2.3 Global Opioid Narcotics Market Average Price (2021-2032)
  6. 2.3 Opioid Narcotics by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Fentanyl
  9. 2.3.3 Remifentanil
  10. 2.3.4 Sufentanil
  11. 2.4 Opioid Narcotics by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Hospital
  14. 2.4.3 Clinic
  15. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Opioid Narcotics Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Opioid Narcotics Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Opioid Narcotics Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Opioid Narcotics Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Opioid Narcotics Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Opioid Narcotics, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Opioid Narcotics, Product Type & Application
  8. 3.8 Global Manufacturers of Opioid Narcotics, Established Date
  9. 3.9 Global Opioid Narcotics Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Yichang Renfu Pharmaceutical Co., Ltd.
  2. 4.1.1 Yichang Renfu Pharmaceutical Co., Ltd. Company Information
  3. 4.1.2 Yichang Renfu Pharmaceutical Co., Ltd. Business Overview
  4. 4.1.3 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  6. 4.1.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
  7. 4.2 Jiangsu Enhua Pharmaceutical Co., Ltd.
  8. 4.2.1 Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information
  9. 4.2.2 Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview
  10. 4.2.3 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  12. 4.2.5 Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Developments
  13. 4.3 Henan Lingrui Pharmaceutical Co., Ltd.
  14. 4.3.1 Henan Lingrui Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Henan Lingrui Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  18. 4.3.5 Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch
  20. 4.4.1 Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information
  21. 4.4.2 Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview
  22. 4.4.3 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio
  24. 4.4.5 Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Developments
  25. 4.5 Changzhou Siyao Pharmaceutical Co., Ltd.
  26. 4.5.1 Changzhou Siyao Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  30. 4.5.5 Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Reig Jofre
  32. 4.6.1 Reig Jofre Company Information
  33. 4.6.2 Reig Jofre Business Overview
  34. 4.6.3 Reig Jofre Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Reig Jofre Opioid Narcotics Product Portfolio
  36. 4.6.5 Reig Jofre Recent Developments
  37. 4.7 Pfizer
  38. 4.7.1 Pfizer Company Information
  39. 4.7.2 Pfizer Business Overview
  40. 4.7.3 Pfizer Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Pfizer Opioid Narcotics Product Portfolio
  42. 4.7.5 Pfizer Recent Developments
  43. 4.8 GSK
  44. 4.8.1 GSK Company Information
  45. 4.8.2 GSK Business Overview
  46. 4.8.3 GSK Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 GSK Opioid Narcotics Product Portfolio
  48. 4.8.5 GSK Recent Developments
  49. 4.9 Fresenius Kabi
  50. 4.9.1 Fresenius Kabi Company Information
  51. 4.9.2 Fresenius Kabi Business Overview
  52. 4.9.3 Fresenius Kabi Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Fresenius Kabi Opioid Narcotics Product Portfolio
  54. 4.9.5 Fresenius Kabi Recent Developments
  55. 4.10 Daiichi Sankyo
  56. 4.10.1 Daiichi Sankyo Company Information
  57. 4.10.2 Daiichi Sankyo Business Overview
  58. 4.10.3 Daiichi Sankyo Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Daiichi Sankyo Opioid Narcotics Product Portfolio
  60. 4.10.5 Daiichi Sankyo Recent Developments
  61. 4.11 AcelRx Pharmaceuticals, Inc
  62. 4.11.1 AcelRx Pharmaceuticals, Inc Company Information
  63. 4.11.2 AcelRx Pharmaceuticals, Inc Business Overview
  64. 4.11.3 AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio
  66. 4.11.5 AcelRx Pharmaceuticals, Inc Recent Developments
  67. 4.12 Abbott
  68. 4.12.1 Abbott Company Information
  69. 4.12.2 Abbott Business Overview
  70. 4.12.3 Abbott Opioid Narcotics Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Abbott Opioid Narcotics Product Portfolio
  72. 4.12.5 Abbott Recent Developments
5 Global Opioid Narcotics Market Scenario by Region
  1. 5.1 Global Opioid Narcotics Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Opioid Narcotics Sales by Region: 2021-2032
  3. 5.2.1 Global Opioid Narcotics Sales by Region: 2021-2026
  4. 5.2.2 Global Opioid Narcotics Sales by Region: 2027-2032
  5. 5.3 Global Opioid Narcotics Revenue by Region: 2021-2032
  6. 5.3.1 Global Opioid Narcotics Revenue by Region: 2021-2026
  7. 5.3.2 Global Opioid Narcotics Revenue by Region: 2027-2032
  8. 5.4 North America Opioid Narcotics Market Facts & Figures by Country
  9. 5.4.1 North America Opioid Narcotics Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Opioid Narcotics Sales by Country (2021-2032)
  11. 5.4.3 North America Opioid Narcotics Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Opioid Narcotics Market Facts & Figures by Country
  16. 5.5.1 Europe Opioid Narcotics Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Opioid Narcotics Sales by Country (2021-2032)
  18. 5.5.3 Europe Opioid Narcotics Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Opioid Narcotics Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Opioid Narcotics Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Opioid Narcotics Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Opioid Narcotics Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Opioid Narcotics Market Facts & Figures by Country
  41. 5.7.1 South America Opioid Narcotics Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Opioid Narcotics Sales by Country (2021-2032)
  43. 5.7.3 South America Opioid Narcotics Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Opioid Narcotics Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Opioid Narcotics Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Opioid Narcotics Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Opioid Narcotics Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Opioid Narcotics Sales by Type (2021-2032)
  2. 6.1.1 Global Opioid Narcotics Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Opioid Narcotics Sales Market Share by Type (2021-2032)
  4. 6.2 Global Opioid Narcotics Revenue by Type (2021-2032)
  5. 6.2.1 Global Opioid Narcotics Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Opioid Narcotics Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Opioid Narcotics Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Opioid Narcotics Sales by Application (2021-2032)
  2. 7.1.1 Global Opioid Narcotics Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Opioid Narcotics Sales Market Share by Application (2021-2032)
  4. 7.2 Global Opioid Narcotics Revenue by Application (2021-2032)
  5. 7.2.1 Global Opioid Narcotics Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Opioid Narcotics Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Opioid Narcotics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Opioid Narcotics Value Chain Analysis
  2. 8.1.1 Opioid Narcotics Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Opioid Narcotics Production Mode & Process
  5. 8.2 Opioid Narcotics Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Opioid Narcotics Distributors
  8. 8.2.3 Opioid Narcotics Customers
9 Global Opioid Narcotics Analyzing Market Dynamics
  1. 9.1 Opioid Narcotics Industry Trends
  2. 9.2 Opioid Narcotics Industry Drivers
  3. 9.3 Opioid Narcotics Industry Opportunities and Challenges
  4. 9.4 Opioid Narcotics Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst